May 29, 2019 Positive data Kalm Cara investors Cara Therapeutics’ stock shot up 18% today on data derisking two key projects.
February 15, 2019 Upcoming events – Pivotal data for Galapagos and Cara Galapagos will discover if filgotinib can hang on to its reputation as one of the safest Jak inhibitors in the industry, while Cara is itching for pivotal trial success with intravenous Korsuva.
